vs
Cytek Biosciences, Inc.（CTKB）与富兰克林柯维（FC）财务数据对比。点击上方公司名可切换其他公司
富兰克林柯维的季度营收约是Cytek Biosciences, Inc.的1.0倍（$64.0M vs $62.1M），富兰克林柯维净利率更高（-5.1% vs -70.9%，领先65.8%），Cytek Biosciences, Inc.同比增速更快（8.1% vs -7.3%），富兰克林柯维自由现金流更多（$-1.6M vs $-1.8M），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs 2.2%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
富兰克林柯维总部位于美国犹他州盐湖城，是一家专业培训指导企业，面向各类组织与个人提供领导力提升、个人效能成长与业务执行领域的培训及评估服务。公司由富兰克林奎斯特与柯维领导力中心于1997年合并成立，最为人熟知的产品包括富兰克林柯维规划系统等。
CTKB vs FC — 直观对比
营收规模更大
FC
是对方的1.0倍
$62.1M
营收增速更快
CTKB
高出15.4%
-7.3%
净利率更高
FC
高出65.8%
-70.9%
自由现金流更多
FC
多$143.0K
$-1.8M
两年增速更快
CTKB
近两年复合增速
2.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $64.0M |
| 净利润 | $-44.1M | $-3.3M |
| 毛利率 | 52.9% | 75.5% |
| 营业利润率 | -9.0% | -5.7% |
| 净利率 | -70.9% | -5.1% |
| 营收同比 | 8.1% | -7.3% |
| 净利润同比 | -557.1% | -378.5% |
| 每股收益（稀释后） | — | $-0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBFC
| Q4 25 | $62.1M | $64.0M | ||
| Q3 25 | $52.3M | $71.2M | ||
| Q2 25 | $45.6M | $67.1M | ||
| Q1 25 | $41.5M | $59.6M | ||
| Q4 24 | $57.5M | $69.1M | ||
| Q3 24 | $51.5M | $84.1M | ||
| Q2 24 | $46.6M | $73.4M | ||
| Q1 24 | $44.9M | $61.3M |
净利润CTKBFC
| Q4 25 | $-44.1M | $-3.3M | ||
| Q3 25 | $-5.5M | $4.4M | ||
| Q2 25 | $-5.6M | $-1.4M | ||
| Q1 25 | $-11.4M | $-1.1M | ||
| Q4 24 | $9.6M | $1.2M | ||
| Q3 24 | $941.0K | $12.0M | ||
| Q2 24 | $-10.4M | $5.7M | ||
| Q1 24 | $-6.2M | $874.0K |
毛利率CTKBFC
| Q4 25 | 52.9% | 75.5% | ||
| Q3 25 | 52.7% | 75.5% | ||
| Q2 25 | 52.3% | 76.5% | ||
| Q1 25 | 48.6% | 76.7% | ||
| Q4 24 | 58.5% | 76.3% | ||
| Q3 24 | 56.3% | 78.1% | ||
| Q2 24 | 54.6% | 76.6% | ||
| Q1 24 | 51.3% | 76.4% |
营业利润率CTKBFC
| Q4 25 | -9.0% | -5.7% | ||
| Q3 25 | -17.6% | 11.1% | ||
| Q2 25 | -23.3% | -3.3% | ||
| Q1 25 | -36.1% | -2.4% | ||
| Q4 24 | 5.2% | 2.1% | ||
| Q3 24 | -8.2% | 21.3% | ||
| Q2 24 | -18.3% | 11.4% | ||
| Q1 24 | -23.9% | 2.4% |
净利率CTKBFC
| Q4 25 | -70.9% | -5.1% | ||
| Q3 25 | -10.5% | 6.1% | ||
| Q2 25 | -12.2% | -2.1% | ||
| Q1 25 | -27.5% | -1.8% | ||
| Q4 24 | 16.8% | 1.7% | ||
| Q3 24 | 1.8% | 14.2% | ||
| Q2 24 | -22.4% | 7.8% | ||
| Q1 24 | -13.8% | 1.4% |
每股收益（稀释后）CTKBFC
| Q4 25 | — | $-0.27 | ||
| Q3 25 | — | $0.34 | ||
| Q2 25 | — | $-0.11 | ||
| Q1 25 | — | $-0.08 | ||
| Q4 24 | — | $0.09 | ||
| Q3 24 | — | $0.89 | ||
| Q2 24 | — | $0.43 | ||
| Q1 24 | — | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $17.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $341.7M | $54.0M |
| 总资产 | $461.5M | $221.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTKBFC
| Q4 25 | $90.9M | $17.5M | ||
| Q3 25 | $93.3M | $31.7M | ||
| Q2 25 | $75.5M | $33.7M | ||
| Q1 25 | $95.3M | $40.4M | ||
| Q4 24 | $98.7M | $53.3M | ||
| Q3 24 | $162.3M | $48.7M | ||
| Q2 24 | $177.9M | $36.6M | ||
| Q1 24 | $168.8M | $40.9M |
股东权益CTKBFC
| Q4 25 | $341.7M | $54.0M | ||
| Q3 25 | $378.6M | $66.9M | ||
| Q2 25 | $377.6M | $65.6M | ||
| Q1 25 | $379.6M | $72.5M | ||
| Q4 24 | $395.7M | $80.6M | ||
| Q3 24 | $385.5M | $83.1M | ||
| Q2 24 | $389.1M | $72.2M | ||
| Q1 24 | $392.6M | $70.8M |
总资产CTKBFC
| Q4 25 | $461.5M | $221.3M | ||
| Q3 25 | $494.9M | $242.9M | ||
| Q2 25 | $493.3M | $218.3M | ||
| Q1 25 | $482.6M | $221.3M | ||
| Q4 24 | $499.5M | $239.9M | ||
| Q3 24 | $491.2M | $261.5M | ||
| Q2 24 | $483.7M | $221.0M | ||
| Q1 24 | $492.1M | $221.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $98.0K |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $-1.6M |
| 自由现金流率自由现金流/营收 | -2.9% | -2.5% |
| 资本支出强度资本支出/营收 | 1.6% | 2.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $5.9M |
8季度趋势，按日历期对齐
经营现金流CTKBFC
| Q4 25 | $-771.0K | $98.0K | ||
| Q3 25 | $-3.9M | $9.9M | ||
| Q2 25 | $108.0K | $6.3M | ||
| Q1 25 | $-125.0K | $-1.4M | ||
| Q4 24 | $2.0M | $14.1M | ||
| Q3 24 | $13.2M | $21.9M | ||
| Q2 24 | $6.2M | $8.2M | ||
| Q1 24 | $4.0M | $12.8M |
自由现金流CTKBFC
| Q4 25 | $-1.8M | $-1.6M | ||
| Q3 25 | $-4.6M | $5.7M | ||
| Q2 25 | $-1.5M | $4.5M | ||
| Q1 25 | $-974.0K | $-2.6M | ||
| Q4 24 | $1.1M | $13.1M | ||
| Q3 24 | $12.2M | $20.8M | ||
| Q2 24 | $5.2M | $7.3M | ||
| Q1 24 | $3.4M | $12.1M |
自由现金流率CTKBFC
| Q4 25 | -2.9% | -2.5% | ||
| Q3 25 | -8.7% | 8.0% | ||
| Q2 25 | -3.2% | 6.7% | ||
| Q1 25 | -2.3% | -4.4% | ||
| Q4 24 | 1.9% | 19.0% | ||
| Q3 24 | 23.7% | 24.7% | ||
| Q2 24 | 11.0% | 9.9% | ||
| Q1 24 | 7.6% | 19.8% |
资本支出强度CTKBFC
| Q4 25 | 1.6% | 2.7% | ||
| Q3 25 | 1.3% | 5.9% | ||
| Q2 25 | 3.5% | 2.7% | ||
| Q1 25 | 2.0% | 2.1% | ||
| Q4 24 | 1.6% | 1.4% | ||
| Q3 24 | 2.0% | 1.3% | ||
| Q2 24 | 2.3% | 1.2% | ||
| Q1 24 | 1.3% | 1.0% |
现金转化率CTKBFC
| Q4 25 | — | — | ||
| Q3 25 | — | 2.27× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | 11.98× | ||
| Q3 24 | 14.05× | 1.83× | ||
| Q2 24 | — | 1.43× | ||
| Q1 24 | — | 14.62× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
FC
暂无分部数据
